MyAverix Finance
F · Healthcare
JW (Cayman) Therapeutics Co. Ltd (JNY)
Biotechnology
JW (Cayman) Therapeutics Co. Ltd (JNY) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $89.98M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for JNY
JW (Cayman) Therapeutics Co. Ltd (JNY) — FAQ
What is JW (Cayman) Therapeutics Co. Ltd's market cap?
JW (Cayman) Therapeutics Co. Ltd (JNY) has a reported market cap of $89.98M (data as of 2026-03-29).
What is JNY's P/E ratio?
The price-to-earnings (P/E) ratio for JW (Cayman) Therapeutics Co. Ltd (JNY) is 18.00 (data as of 2026-03-29).
Does JW (Cayman) Therapeutics Co. Ltd pay a dividend?
Dividend yield is not available in the current snapshot for JW (Cayman) Therapeutics Co. Ltd (JNY). Check the MyAverix Finance app for the latest dividend data.
What sector is JW (Cayman) Therapeutics Co. Ltd in?
JW (Cayman) Therapeutics Co. Ltd (JNY) is classified in the Healthcare sector (Biotechnology industry).
What exchange is JNY listed on?
JNY is listed on F.
What is JW (Cayman) Therapeutics Co. Ltd's net margin?
JW (Cayman) Therapeutics Co. Ltd (JNY) reports a net margin of 0.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.